Medical device company Diality Inc., based in Irvine, California, is excited to announce the appointment of Ravi Parthasarathy as Chief Technology Officer. With a wealth of experience in product development team leadership, Parthasarathy most recently worked at ICU Medical as Vice President of Device Engineering. He has also held leadership roles at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.
Diality CEO Osman Khawar expressed his excitement about the addition to the team, citing Parthasarathy’s experience in developing innovative products and his alignment with Diality’s mission and values. In addition to Parthasarathy’s appointment, Clayton Poppe will take on the role of Chief Scientific Officer (CSO) to lead the company’s research, quality, and regulatory functions.
The Moda-flxTM Hemodialysis System developed by Diality aims to provide healthcare professionals with the tools they need to make patient-centered decisions and improve clinical practice. Parthasarathy shared his enthusiasm for contributing to the development of this system, highlighting the importance of innovation in improving the quality of life and care for dialysis patients.
Based in Irvine, California, Diality focuses on developing cutting-edge medical devices that improve patient outcomes. For more information about Diality or its Moda-flxTM Hemodialysis System, please visit www.diality.com or find Diality on LinkedIn. For media inquiries
